SOLU-CORTEF® Description
(hydrocortisone sodium succinate)
DESCRIPTION
SOLU-CORTEF Sterile Powder is an anti-inflammatory glucocorticoid that contains hydrocortisone sodium succinate as the active ingredient. SOLU-CORTEF Sterile Powder is available in several packages for intravenous or intramuscular administration.
100 mg Plain
Vials containing hydrocortisone sodium succinate equivalent to 100 mg hydrocortisone, 0.8 mg monobasic sodium phosphate anhydrous, 8.73 mg dibasic sodium phosphate dried. SOLU-CORTEF 100 mg plain does not contain diluent (see DOSAGE AND ADMINISTRATION, Preparation of Solutions).
| 100 mg ACT-O-VIAL | 250 mg ACT-O-VIAL | 500 mg ACT-O-VIAL | 1,000 mg ACT-O-VIAL | |
|---|---|---|---|---|
| Each 2 mL contains (when mixed): | Each 2 mL contains (when mixed): | Each 4 mL contains (when mixed): | Each 8 mL contains (when mixed): | |
Hydrocortisone | equiv. to | equiv. to | equiv. to | equiv. to |
Monobasic sodium | 0.8 mg | 2 mg | 4 mg | 8 mg |
Dibasic sodium | 8.73 mg | 21.8 mg | 44 mg | 87.32 mg |
The diluent, as part of the packaging presentation for the ACT-O-VIAL system, is comprised of Water for Injection only, and does not contain any preservative.
When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8.
The chemical name for hydrocortisone sodium succinate is pregn-4-ene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11β)- and its molecular weight is 484.52.
The structural formula is represented below:
Hydrocortisone sodium succinate is a white or nearly white, odorless, hygroscopic amorphous solid. It is very soluble in water and in alcohol, very slightly soluble in acetone, and insoluble in chloroform.
Find SOLU-CORTEF® medical information:
Find SOLU-CORTEF® medical information:
SOLU-CORTEF® Quick Finder
Health Professional Information
Description
DESCRIPTION
SOLU-CORTEF Sterile Powder is an anti-inflammatory glucocorticoid that contains hydrocortisone sodium succinate as the active ingredient. SOLU-CORTEF Sterile Powder is available in several packages for intravenous or intramuscular administration.
100 mg Plain
Vials containing hydrocortisone sodium succinate equivalent to 100 mg hydrocortisone, 0.8 mg monobasic sodium phosphate anhydrous, 8.73 mg dibasic sodium phosphate dried. SOLU-CORTEF 100 mg plain does not contain diluent (see DOSAGE AND ADMINISTRATION, Preparation of Solutions).
| 100 mg ACT-O-VIAL | 250 mg ACT-O-VIAL | 500 mg ACT-O-VIAL | 1,000 mg ACT-O-VIAL | |
|---|---|---|---|---|
| Each 2 mL contains (when mixed): | Each 2 mL contains (when mixed): | Each 4 mL contains (when mixed): | Each 8 mL contains (when mixed): | |
Hydrocortisone | equiv. to | equiv. to | equiv. to | equiv. to |
Monobasic sodium | 0.8 mg | 2 mg | 4 mg | 8 mg |
Dibasic sodium | 8.73 mg | 21.8 mg | 44 mg | 87.32 mg |
The diluent, as part of the packaging presentation for the ACT-O-VIAL system, is comprised of Water for Injection only, and does not contain any preservative.
When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8.
The chemical name for hydrocortisone sodium succinate is pregn-4-ene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11β)- and its molecular weight is 484.52.
The structural formula is represented below:
Hydrocortisone sodium succinate is a white or nearly white, odorless, hygroscopic amorphous solid. It is very soluble in water and in alcohol, very slightly soluble in acetone, and insoluble in chloroform.
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.